Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...
Over 80% of enterprises are turning to open-source AI models. However, the challenge isn't accessing powerful models, rather it's deploying them efficiently and securely. Today, companies must stitch ...